Skip to main content

Luís Gros Subias

Institutions of which they are part

Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Luís Gros Subias

Institutions of which they are part

Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Projects

Red Temática de Investigación Cooperativa en Cáncer - RTICC

IP: Josep Sánchez de Toledo Codina
Collaborators: Red Temática de Investigación Cooperativa en Cáncer - RTICC, Luís Gros Subias, Pablo Velasco Puyó, Aroa Soriano Fernández, Maria Cristina Díaz de Heredia Rubio, Miguel Segura Ginard, Constantino Sábado Álvarez, Anna Llort Sales, Laura Alonso Garcia, Josep Roma Castanyer
Funding agency: Instituto de Salud Carlos III
Funding: 186750
Reference: RD12/0036/0016
Duration: 01/01/2013 - 30/06/2017

Calidad de vida en pacientes pediátricos afectos de tumores en el Sistema Nervioso Central. Papel modulador del as secuelas y de las estrategias de afrontamiento de los padres

IP: -
Collaborators: Luís Gros Subias, Constantino Sábado Álvarez, Anna Llort Sales
Funding agency: Asociación Española Contra el Cáncer
Funding: 18000
Reference: AECC 6/2008
Duration: 22/01/2009 - 21/01/2011

Identificación de nuevas dianas terapéuticas en el rabdomiosarcoma: efectos de la silenciación de las vías de señalización celular de NOTCH, Hedgehog y RAS en esta neoplasia

IP: -
Collaborators: Luís Gros Subias, Constantino Sábado Álvarez, Josep Roma Castanyer
Funding agency: Asociación Española Contra el Cáncer
Funding: 18000
Reference: AECC_CAT_01_2007
Duration: 21/01/2008 - 20/01/2010

RTICC - Red Temática de Investigación cooperativa de cáncer

IP: Josep Sánchez de Toledo Codina
Collaborators: RTICC - Red Temática de Investigación cooperativa de cáncer, Luís Gros Subias, Maria Cristina Díaz de Heredia Rubio, Miguel Segura Ginard, Constantino Sábado Álvarez, Anna Llort Sales, Josep Roma Castanyer
Funding agency: Instituto de Salud Carlos III
Funding: 51990
Reference: RD06/0020/1021
Duration: 01/01/2008 - 31/12/2014

Related news

"Generation of a bank of surgical orthotopic PDX (patient-derived xenografts) models within the framework of a personalized medicine program in pediatric cancer" was the awarded work, of the Childhood Cancer and Hematological Diseases Group of VHIR.

A study, co-led by Vall d’Hebron, has analysed the evolution of clinical trials with children and adolescents with cancer over the last 15 years, with the aim of optimising efficacy and defining lines for further progress.

The research team has shown that inhibiting the TRIB3 protein slows the growth of rhabdomyosarcoma and improves survival in animal models.

Related professionals

Lorena Ramirez Orihuela

Lorena Ramirez Orihuela

Research technician
Transfusional Medicine
Read more
Samanta Mecocci

Samanta Mecocci

Read more
Lluria Cornellas Escayola

Lluria Cornellas Escayola

Read more
Patricia Rubio Garrido

Patricia Rubio Garrido

Multidisciplinary Nursing Research Group
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.